| Serial Number | 90382660 |
| Word Mark | GENZELENT |
| Filing Date | Tuesday, December 15, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, October 9, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 13, 2021 |
| Goods and Services | Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 23, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Tuesday, October 10, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, October 9, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, February 21, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, February 17, 2023 | SOU EXTENSION 3 GRANTED |
| Friday, February 17, 2023 | SOU EXTENSION 3 FILED |
| Friday, February 17, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, August 26, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, August 24, 2022 | SOU EXTENSION 2 GRANTED |
| Wednesday, August 24, 2022 | SOU EXTENSION 2 FILED |
| Wednesday, August 24, 2022 | SOU TEAS EXTENSION RECEIVED |
| Saturday, February 19, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, February 17, 2022 | SOU EXTENSION 1 GRANTED |
| Thursday, February 17, 2022 | SOU EXTENSION 1 FILED |
| Thursday, February 17, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, September 7, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 13, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 13, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 23, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, June 4, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, June 3, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 3, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 3, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 31, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 31, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, May 31, 2021 | NON-FINAL ACTION WRITTEN |
| Saturday, May 29, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, February 23, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, December 18, 2020 | NEW APPLICATION ENTERED |